NSN 6505-01-656-4667 Fentanyl Transdermal System manufactured by Mylan Pharmaceuticals Inc, Actavis Pharma Inc, Sandoz Inc, Par Pharmaceutical Inc, Janssen Pharmaceuticals Inc is available within ASAP Part Service’s ready-to-ship inventory. Owned and operated by ASAP Semiconductor, ASAP Part Services has over 6 billion parts within its inventory including NDC00378-9123-98, NDC00591-3213-72, NDC00781-7243-55, NDC49884-0763-78, NDC50458-0093-05. ASAP is committed to streamlining the parts procurement process for our customers. We make it easy for our customers to search through billions of parts to find the exact part they are looking for.
A dedicated ASAP account manager is ready to help solve any procurement issues or needs that a customer may have. As a company we are quick and responsive meaning we can deliver a part within an AOG timeframe. Quality control is at the center of all that we do. Each and every NSN 6505-01-656-4667 part is subject to numerous quality checks that are designed to screen out any part imperfections or validity issues. Subject a request for quote for NSN 6505-01-656-4667 part today and allow us to simplify your procurement process.
Alternative NSN: 6505-01-656-4667 |
Item Name:Fentanyl Transdermal System |
NCB Code: USA (01) |
Manufacturers: Mylan Pharmaceuticals Inc , Actavis Pharma Inc , Sandoz Inc , Par Pharmaceutical Inc , Janssen Pharmaceuticals Inc |
Mylan Pharmaceuticals Inc | Actavis Pharma Inc | Sandoz Inc |
Par Pharmaceutical Inc | Janssen Pharmaceuticals Inc |
Part No Part No
|
Manufacturer NSN Parts
|
Item Name Item Name
|
QTY QTY
|
RFQ RFQ
|
---|---|---|---|---|
NDC00378-9123-98 | Mylan Pharmaceuticals Inc | fentanyl transdermal system | Avl | RFQ |
NDC00591-3213-72 | Actavis Pharma Inc | fentanyl transdermal system | Avl | RFQ |
NDC00781-7243-55 | Sandoz Inc | fentanyl transdermal system | Avl | RFQ |
NDC49884-0763-78 | Par Pharmaceutical Inc | fentanyl transdermal system | Avl | RFQ |
NDC50458-0093-05 | Janssen Pharmaceuticals Inc | fentanyl transdermal system | Avl | RFQ |
MRC | Criteria | Characteristic |
---|---|---|
FEAT | Special Features | ROUTE: TRANSDERMAL; DOSE FORM: PATCH, TRANSDERMAL 72 HOURS; STRENGTH: 75 MCG/HOUR; DEA CONTROLLED II SUBSTANCE; INDIVIDUALLY SEALED; CONTAINS FIVE (75 MCG/HR) TRANSDERMAL SYSTEMS; STORE IN ORIGINAL UNOPENED POUCH. STORE UP TO 20 C TO 25 C (68 F TO 77 F; STRICT ADHERENCE TO THE RECOMMENDED HANDLING AND DISPOSAL INSTRUCTIONS ON PRODUCT INSERT IS OF THE UTMOST IMPORTANCE TO PREVENT ACCIDENTAL EXPOSURE; EXPOSURE OF FENTANYL TRANSDERMAL SYSTEM APPLICATION SITE AND SURROUNDING AREA TO DIRECT EXTERNAL HEAT SOURCES, SUCH AS HEATING PADS, SAUNAS, HOT TUBS AND HEATED WATER BEDS MAY INCREASE FENTANYL ABSORPTION AND RESULT IN FATAL OVERDOSE OF FENTANYL AND DEATH; PATIENTS WHO DEVELOP FEVER OR INCREASED CORE BODY TEMPERATURE DUE TO STRENOUS EXERTION ARE ALSO AT RISK FOR INCREASED FENTANYL EXPOSURE AND MAY REQUIRE AN ADJUSTMENT IN THE DOSE OF FENTANYL TRANSDERMAL SYSTEM TO AVOID OVERDOSE |
CSLZ | Usual Dose | 75 MCG/HR |
CBBL | Features Provided | INDIVIDUALLY SEALED |
CRYC | Controlled Substance Classification | SCHEDULE II |
CXCY | Part Name Assigned By Controlling Agency | DURAGESIC-75 (FENTANYL TRANSDERMAL SYSTEM) 75MCG/HR, 5S |
MRC | Decoded Requirement | Clear Text Reply |
All Orders are Fulfilled in the U.S.A.
All shipments must comply with U.S.A export laws.
No exceptions.
The only independent distributor
with a NO CHINA SOURCING Pledge
“We Proudly Support Intrepid Fallen Heroes Fund that serves United States Military Personal experiencing the Invisible Wounds of War : Traumatic Brain Injury (TBI) and Post Traumatic Stress (PTS). Please visit website (www.fallenheroesfund.org) and help in their valiant effort”.
Remember Us the Next Time You’re Looking for NSN Parts. We Can Get You Some of the Quickest and Most Competitive Quotes In the Industry.
Request for Quote